Hendrik Houthoff

20172018
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2018

In vivo characterization of platinum (II)-based linker technology for the development of antibody-drug conjugates: Taking advantage of dual labeling with 195mPt and 89Zr

Muns, J. A., Montserrat, V., Houthoff, H. J., Codée-Van Der Schilden, K., Zwaagstra, O., Sijbrandi, N. J., Merkul, E. & Van Dongen, G. A. M. S., 1 Jul 2018, In : Journal of Nuclear Medicine. 59, 7, p. 1146-1151 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

A novel platinum(II)-based bifunctional ADC linker benchmarked using 89Zr-Desferal and auristatin F-conjugated trastuzumab

Sijbrandi, N. J., Merkul, E., Muns, J. A., Waalboer, D. C. J., Adamzek, K., Bolijn, M., Montserrat, V., Somsen, G. W., Haselberg, R., Steverink, P. J. G. M., Houthoff, H. J. & Van Dongen, G. A. M. S., 15 Jan 2017, In : Cancer Research. 77, 2, p. 257-267 11 p.

Research output: Contribution to journalArticleAcademicpeer-review